Literature DB >> 9549452

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

R C Turner1, H Millns, H A Neil, I M Stratton, S E Manley, D R Matthews, R R Holman.   

Abstract

OBJECTIVE: To evaluate baseline risk factors for coronary artery disease in patients with type 2 diabetes mellitus.
DESIGN: A stepwise selection procedure, adjusting for age and sex, was used in 2693 subjects with complete data to determine which risk factors for coronary artery disease should be included in a Cox proportional hazards model.
SUBJECTS: 3055 white patients (mean age 52) with recently diagnosed type 2 diabetes mellitus and without evidence of disease related to atheroma. Median duration of follow up was 7.9 years. 335 patients developed coronary artery disease within 10 years. OUTCOME MEASURES: Angina with confirmatory abnormal electrocardiogram; non-fatal and fatal myocardial infarction.
RESULTS: Coronary artery disease was significantly associated with increased concentrations of low density lipoprotein cholesterol, decreased concentrations of high density lipoprotein cholesterol, and increased triglyceride concentration, haemoglobin A1c, systolic blood pressure, fasting plasma glucose concentration, and a history of smoking. The estimated hazard ratios for the upper third relative to the lower third were 2.26 (95% confidence interval 1.70 to 3.00) for low density lipoprotein cholesterol, 0.55 (0.41 to 0.73) for high density lipoprotein cholesterol, 1.52 (1.15 to 2.01) for haemoglobin A1c, and 1.82 (1.34 to 2.47) for systolic blood pressure. The estimated hazard ratio for smokers was 1.41 (1.06 to 1.88).
CONCLUSION: A quintet of potentially modifiable risk factors for coronary artery disease exists in patients with type 2 diabetes mellitus. These risk factors are increased concentrations of low density lipoprotein cholesterol, decreased concentrations of high density lipoprotein cholesterol, raised blood pressure, hyperglycaemia, and smoking.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9549452      PMCID: PMC28484          DOI: 10.1136/bmj.316.7134.823

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  41 in total

1.  Body weight and mortality among women.

Authors:  J E Manson; W C Willett; M J Stampfer; G A Colditz; D J Hunter; S E Hankinson; C H Hennekens; F E Speizer
Journal:  N Engl J Med       Date:  1995-09-14       Impact factor: 91.245

2.  Mortality in diabetic subjects: an eleven-year follow-up of a community-based population.

Authors:  D P Walters; W Gatling; A C Houston; M A Mullee; S A Julious; R D Hill
Journal:  Diabet Med       Date:  1994-12       Impact factor: 4.359

3.  NIDDM and its metabolic control predict coronary heart disease in elderly subjects.

Authors:  J Kuusisto; L Mykkänen; K Pyörälä; M Laakso
Journal:  Diabetes       Date:  1994-08       Impact factor: 9.461

4.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

5.  Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.

Authors:  M I Uusitupa; L K Niskanen; O Siitonen; E Voutilainen; K Pyörälä
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

6.  Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.

Authors:  M Kawamura; J W Heinecke; A Chait
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

Authors:  M R Law; N J Wald; S G Thompson
Journal:  BMJ       Date:  1994-02-05

8.  Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women.

Authors:  I Stensvold; A Tverdal; P Urdal; S Graff-Iversen
Journal:  BMJ       Date:  1993-11-20

Review 9.  Hyperglycemia and microvascular and macrovascular disease in diabetes.

Authors:  R Klein
Journal:  Diabetes Care       Date:  1995-02       Impact factor: 19.112

10.  UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects.

Authors: 
Journal:  Diabet Med       Date:  1994-07       Impact factor: 4.359

View more
  399 in total

Review 1.  Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?

Authors:  F Dunne; M J Kendall; U Martin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Role of ACE inhibitors in patients with diabetes mellitus.

Authors:  D J Cordonnier; P Zaoui; S Halimi
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

Review 4.  Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings.

Authors:  C M Renders; G D Valk; S Griffin; E H Wagner; J T Eijk; W J Assendelft
Journal:  Cochrane Database Syst Rev       Date:  2001

5.  Impaired glucose tolerance plus hyperlipidaemia induced by diet promotes retina microaneurysms in New Zealand rabbits.

Authors:  Tatiana Helfenstein; Francisco A Fonseca; Sílvia S Ihara; Juliana M Bottós; Flávio T Moreira; Henrique Pott; Michel E Farah; Maria C Martins; Maria C Izar
Journal:  Int J Exp Pathol       Date:  2011-02       Impact factor: 1.925

Review 6.  Treatment of hypertension in diabetic patients with nephropathy.

Authors:  R Komers; S Anderson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 7.  Diagnosis of CAD in patients with diabetes: who to evaluate.

Authors:  Lawrence H Young; Powell Jose; Deborah Chyun
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 8.  Prediabetes mellitus and its links to atherosclerosis.

Authors:  Daniel Kramer; Annaswamy Raji; Jorge Plutzky
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 9.  Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents.

Authors:  Jian Shen; Jose M Ordovas
Journal:  Clin Chem       Date:  2008-12-12       Impact factor: 8.327

10.  Poor lipid control in type-2 diabetics with and without ischemic heart disease.

Authors:  Daad H Akbar; Aish A Al-Gamdi; Nariman A Hejazi
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.